Stephen Anthony Stamp Insider Profile
4 Followers
Stephen Anthony Stamp, Chief Financial Officer at Biodexa Pharmaceuticals, holds 1.00M shares in Biodexa Pharmaceuticals (Ticker: BDRX), holds 200.00K shares in Ergomed (Ticker: GB:ERGO), holds 1.00M shares in Midatech Pharma (Ticker: GB:BDRX). Most recently, Stephen Anthony Stamp Bought ― shares of Biodexa Pharmaceuticals on Oct 07, 2019 for an estimated value of $30.38K.
Stephen Anthony Stamp's Trading History
| BDRXBiodexa Pharmaceuticals | Oct 07, 2019 | Chief Financial Officer | Informative Buy | 30.38K | $2.24M | |
| ERGOErgomed | May 04, 2016 | ― | Informative Buy | 280.00K | £2.69M | |
| SHPShire plc | ― | ― | ― | ― | ||
| BDRXMidatech Pharma | ― | ― | ― | £37.50K |
You May Also Like
Stephen Anthony Stamp insider profile FAQ
What is the percentage of profitable transactions made by Stephen Anthony Stamp?
The percentage of profitable transactions made by Stephen Anthony Stamp is 20%.
What is the average return per transaction made by Stephen Anthony Stamp?
The average return per transaction made by Stephen Anthony Stamp is -51.40%.
What stocks does Stephen Anthony Stamp hold?
Stephen Anthony Stamp holds: BDRX, GB:ERGO, GB:BDRX, GB:SHP stocks.
What was Stephen Anthony Stamp’s latest transaction?
Stephen Anthony Stamp’s latest transaction was an Informative Buy of $30.38K.
What was Stephen Anthony Stamp's most profitable transaction?
Stephen Anthony Stamp’s most profitable transaction was an Informative Buy of GB:ERGO stock on May 4, 2016. The return on the trade was 39.40%.
What is Stephen Anthony Stamp's role in Biodexa Pharmaceuticals?
Stephen Anthony Stamp's role in Biodexa Pharmaceuticals is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
